CFDE Data Portal | Search H3P13

	Label	Description
	H3P13 Gene (Entity type)	ENSG00000243977 - H3 histone pseudogene 13
	GSE236502 paclitaxel 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233112 doxorubicin 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 11 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE133749 BMPR2 overexpression endothelial cell 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Blood 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Testis 20-29 vs 50-59 Up Gene Set (Entity type)	A Gene Set from GTEx
	GSE111247 temozolomide LN-308 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233776 AXL receptor tyrosine kinase inhibition 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS

H3P13

ENSG00000243977 - H3 histone pseudogene 13

GSE236502 paclitaxel 1 v 3 human up

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 2 v 4 human dn

A Gene Set from LINCS

GSE233112 doxorubicin 2 v 0 human dn

A Gene Set from LINCS

GSE252944 AKT inhibition 11 v 9 human up

A Gene Set from LINCS

GSE133749 BMPR2 overexpression endothelial cell 0 v 4 human dn

A Gene Set from LINCS

GTEx Blood 20-29 vs 30-39 Down

A Gene Set from GTEx

GTEx Testis 20-29 vs 50-59 Up

A Gene Set from GTEx

GSE111247 temozolomide LN-308 2 v 3 human up

A Gene Set from LINCS

GSE233776 AXL receptor tyrosine kinase inhibition 0 v 1 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.